{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-079631","form_type":"8-K","ticker":"ALBT","cik":"0001630212","company_name":"Avalon GloboCare Corp.","filed_at":"2022-12-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.496101+00:00","generated_at":"2026-06-21T04:47:46.344472+00:00","sec_items":["1.01","5.03","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Avalon GloboCare closes $4M private placement with Chairman for lab services acquisition","bullets":["Chairman Daniel Lu invested $4M in Series A preferred stock convertible at min $1.00/share.","Proceeds to fund 60% acquisition of Laboratory Services MSO; another $6M raise planned.","Preferred stock has 9-month conversion lock-up and 10% monthly sale limit.","Acquisition expected to close within 30 days; management calls it transformative with positive cash flow."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-079631","json":"https://secwatch.observer/filing/0001213900-22-079631.json","markdown":"https://secwatch.observer/filing/0001213900-22-079631.md","text":"https://secwatch.observer/filing/0001213900-22-079631.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630212/000121390022079631/0001213900-22-079631-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630212/000121390022079631/ea170113-8k_avalonglobo.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T04:47:46.344472+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ac7e0a44b5e880c38303d896c828d20120dd214f","claim":"Avalon GloboCare Corp.: Filed Certificate of Designation for Series A Preferred Stock, designating up to 15,000 shares and setting preferences, rights, and limitations (effective 2022-11-03).","evidence_excerpt":"On November 3, 2022 the Company filed a Certificate of Designation of Preferences, Rights and Limitations of the Series A Preferred Stock (the “ Series A Certificate of Designation ”), which became effective immediately with the Secretary of State of the State of Delaware, attached hereto as Exhibit 3.1.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390022079631/0001213900-22-079631-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2022-11-03"}],"fact_type":"governance_change"},{"claim_id":"3a44855fea490c739aa47da11a5a4fac9d289afc","claim":"Avalon GloboCare Corp. entered into Securities Purchase Agreement with Wenzhao Lu valued at $4,000,000 (effective 2022-12-14).","evidence_excerpt":"On December 14, 2022, the Company entered into a Securities Purchase Agreement with Wenzhao Lu, the Company’s Chairman of the Board, pursuant to which the Company sold to Mr. Lu 4,000 shares of its Series A Preferred Stock, stated value $1,000, for the gross proceeds of $4,000,000 (the “ Private Placement ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390022079631/0001213900-22-079631-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"Wenzhao Lu"},{"label":"Value","value":"$4,000,000"},{"label":"Effective","value":"2022-12-14"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}